Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H33N7O5 |
| Molecular Weight | 463.5306 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(N)C(=O)N[C@H](COCC1=CC=CC=C1)C2=NN=NN2CCOC(=O)NCCCCO
InChI
InChIKey=KJXOYJXMFGXDRR-QGZVFWFLSA-N
InChI=1S/C21H33N7O5/c1-21(2,22)19(30)24-17(15-32-14-16-8-4-3-5-9-16)18-25-26-27-28(18)11-13-33-20(31)23-10-6-7-12-29/h3-5,8-9,17,29H,6-7,10-15,22H2,1-2H3,(H,23,31)(H,24,30)/t17-/m1/s1
| Molecular Formula | C21H33N7O5 |
| Molecular Weight | 463.5306 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 21:49:49 GMT 2025
by
admin
on
Tue Apr 01 21:49:49 GMT 2025
|
| Record UNII |
D9Y5DGD9EI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
295337-71-2
Created by
admin on Tue Apr 01 21:49:49 GMT 2025 , Edited by admin on Tue Apr 01 21:49:49 GMT 2025
|
PRIMARY | |||
|
23649669
Created by
admin on Tue Apr 01 21:49:49 GMT 2025 , Edited by admin on Tue Apr 01 21:49:49 GMT 2025
|
PRIMARY | |||
|
D9Y5DGD9EI
Created by
admin on Tue Apr 01 21:49:49 GMT 2025 , Edited by admin on Tue Apr 01 21:49:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
A cell-based functional FLIPR assay was developed from H4 glioma cells in which expression of the endogenous human GHS receptor was enhanced by RAGE-activation.Ghrelin EC50 = 1.4.
EC50
|
||
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
